The Transcription Factor Mrr1p Controls Expression of the MDR1 Efflux Pump and Mediates Multidrug Resistance in Candida albicans
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Constitutive overexpression of the MDR1 (multidrug resistance) gene, which encodes a multidrug efflux pump of the major facilitator superfamily, is a frequent cause of resistance to fluconazole and other toxic compounds in clinical Candida albicans strains, but the mechanism of MDR1 upregulation has not been resolved. By genome-wide gene expression analysis we have identified a zinc cluster transcription factor, designated as MRR1 (multidrug resistance regulator), that was coordinately upregulated with MDR1 in drug-resistant, clinical C. albicans isolates. Inactivation of MRR1 in two such drug-resistant isolates abolished both MDR1 expression and multidrug resistance. Sequence analysis of the MRR1 alleles of two matched drug-sensitive and drug-resistant C. albicans isolate pairs showed that the resistant isolates had become homozygous for MRR1 alleles that contained single nucleotide substitutions, resulting in a P683S exchange in one isolate and a G997V substitution in the other isolate. Introduction of these mutated alleles into a drug-susceptible C. albicans strain resulted in constitutive MDR1 overexpression and multidrug resistance. By comparing the transcriptional profiles of drug-resistant C. albicans isolates and mrr1Delta mutants derived from them and of C. albicans strains carrying wild-type and mutated MRR1 alleles, we defined the target genes that are controlled by Mrr1p. Many of the Mrr1p target genes encode oxidoreductases, whose upregulation in fluconazole-resistant isolates may help to prevent cell damage resulting from the generation of toxic molecules in the presence of fluconazole and thereby contribute to drug resistance. The identification of MRR1 as the central regulator of the MDR1 efflux pump and the elucidation of the mutations that have occurred in fluconazole-resistant, clinical C. albicans isolates and result in constitutive activity of this trancription factor provide detailed insights into the molecular basis of multidrug resistance in this important human fungal pathogen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Construction of mrr1Δ Mutants and Complemented Strains (A) Structure of the deletion cassette from plasmid pZCF36M2 (top), which was used to delete the MRR1 ORF in strains SC5314, F5, G5, and CAG48B, and genomic structure of the MRR1 locus in the parental strains (bottom). The MRR1 coding region is represented by the white arrow and the upstream and downstream regions (5′MRR1 and 3′MRR1) by the solid lines. The SAT1 flipper cassette (SAT1-FLIP), in which the caFLP gene is expressed from the inducible SAP2 promoter [30], is represented by the grey rectangle bordered by FRT sites (black arrows). The 34 bp FRT sites are not drawn to scale. The probes used for Southern hybridization analysis of the mutants are indicated by the black bars. (B) Structure of the DNA fragments from plasmids pZCF36K2, pZCF36K3, pZCF36K4, and pZCF36K5 (top), which were used for integration the MRR1 F2–1, MRR1 F5, MRR1 G2–2, and MRR1 G5 alleles, respectively, into the disrupted mrr1 locus of homozygous and heterozygous mrr1Δ mutants (bottom) using the caSAT1 selection marker (grey arrow). TACT1, transcription termination sequence of the ACT1 gene. Only relevant restriction sites are given in (A) and (B): A, ApaI; B, BglII; E, EcoRI; N, NsiI; Nd, NdeI; P, PstI; S, SalI; ScI, SacI; ScII, SacII; X, XhoI. The PstI and NsiI sites shown in parenthesis were destroyed by the cloning procedure. (C) Southern hybridization of NsiI-digested genomic DNA of mrr1Δ mutants derived from strain SC5314 and of strains with reinserted MRR1 alleles with the MRR1-specific probe 1. The sizes of the hybridizing fragments (in kb) are given on the left side of the blot and their identities are indicated on the right. The genotype of the strains is given above the respective lanes. Only one of the two independently constructed series of strains is shown. Inactivation of MRR1 in the clinical isolates F5 and G5 and the reporter strain CAG48B and reinsertion of different MRR1 alleles in mrr1 mutants of the reporter strain occurred in an analogous fashion.](https://figures.cochat.ai/paper-figures/92ad36a1a1ee4d74832061200ec93001/the-transcription-factor-mrr1p-controls-expression-of-the-mdr1-efflux-pump-and-figure-2.jpg)




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The mutual dependence of Mrr1 and Snf2 occupancy at the MDR1 promoter is consistent with their requirements for MDR1 transcriptional activation (17) (Fig. 1).”
From Candida albicans Swi/Snf and Mediator Complexes Differentially Regulate Mrr1-Induced MDR1 Expression and Fluconazole Resistance (2017) · cites this paper as [17]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Hyperactivation of Mrr1 by xenobiotics and the subsequent expression of MDR1 play a key role in detoxifying compounds such as benomyl (17, 19–21).”
From Candida albicans Swi/Snf and Mediator Complexes Differentially Regulate Mrr1-Induced MDR1 Expression and Fluconazole Resistance (2017) · cites this paper as [17]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interestingly, deletion of MRR1 in each MDR1-overexpressing isolate did not yield identical MICs to strains lacking MDR1 in the same background.”
From Molecular and genetic basis of azole antifungal resistance in the opportunistic pathogenic fungus Candida albicans (2020) · cites this paper as [103]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Expression of MDR1 is the major, but not the exclusive, fluconazole resistance pathway in strains with MRR1GOF mutations (17, 19).”
From Candida albicans Swi/Snf and Mediator Complexes Differentially Regulate Mrr1-Induced MDR1 Expression and Fluconazole Resistance (2017) · cites this paper as [17]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“MRR1GOF mutations induce drug efflux gene expression and are commonly found in fluconazole-resistant C. albicans clinical isolates (1, 2, 17, 18).”
From Candida albicans Swi/Snf and Mediator Complexes Differentially Regulate Mrr1-Induced MDR1 Expression and Fluconazole Resistance (2017) · cites this paper as [17]
Experimental — accuracy not yet measured
18 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
White, T. C., Marr, K. A., & Bowden, R. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.382 · Cited by 1,353 · cited 1×
“candidiasis, which frequently affects HIV-infected persons and AIDS patients [2].”
BackgroundA rapid and simple method for preparation of RNA from Saccharomyces cerevisiae
Schmitt, M. E., Brown, T. A., & Trumpower, B. L. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.10.3091 · Cited by 1,338 · cited 1×
“Total RNA was isolated using the hot SDS-phenol method [52].”
MethodSanglard, D., Kuchler, K., Ischer, F., Pagani, J. L., Monod, M., & Bille, J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2378 · Cited by 815 · cited 1×
“years ago [3], many studies have shown that the major mechanism of resistance to the widely used antifungal agent fluconazole in clinical C.”
BackgroundThe SAT1 flipper, an optimized tool for gene disruption in Candida albicans
Reuß, O., Vik, Å., Kolter, R., & Morschhäuser, J. (2004) · Gene · doi:10.1016/j.gene.2004.06.021 · Cited by 742
Self-citationWhite, T. C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1482 · Cited by 612 · cited 2×
“isolates from the same patient, so-called matched isolates, have proved an excellent tool to study the molecular basis of drug resistance [3–10].”
MethodSanglard, D., Ischer, F., Monod, M., & Bille, J. (1997) · Microbiology · doi:10.1099/00221287-143-2-405 · Cited by 587
Prasad, R., De Wergifosse, P., Goffeau, A., & Balzi, E. (1995) · Current Genetics · doi:10.1007/bf00352101 · Cited by 486
Perea, S., López-Ribot, J. L., Kirkpatrick, W. R., McAtee, R. K., Santillán, R. A., Martı́nez, M., Calabrese, D., Sanglard, D., & Patterson, T. F. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.10.2676-2684.2001 · Cited by 470 · cited 2×
“isolates from the same patient, so-called matched isolates, have proved an excellent tool to study the molecular basis of drug resistance [3–10].”
MethodSanglard, D., Ischer, F., Koymans, L., & Bille, J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.2.241 · Cited by 465 · cited 1×
“isolates from the same patient, so-called matched isolates, have proved an excellent tool to study the molecular basis of drug resistance [3–10].”
MethodCoste, A. T., Karababa, M., Ischer, F., Bille, J., & Sanglard, D. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.6.1639-1652.2004 · Cited by 407 · cited 8×
“Two main factors, namely 1) the discovery of a cis-regulatory element in the promoters of CDR1 and CDR2 with features that are typical of binding sites of zinc cluster transcription factors, and 2) the observation that homozygosity at the mating type locus was linked with the development of azole resistance in certain…”
BackgroundInfluential
Research works printed but not linked: 1
- OddsFC 1988 Candida and candidosis: a review and bibliography London Bailliere Tindall
Cited by
Items 201–300 of 359
Chow, E. W. L., Song, Y., Chen, J., Xu, X., Wang, J., Chen, K., Gao, J., & Wang, Y. (2023) · mBio · doi:10.1128/mbio.02688-23 · Cited by 22
“In Candida albicans , overexpression of CDR1 and MDR1 is controlled by the transcription factors Tac1 (30, 31) and Mrr1 (32, 33), respectively.”
BackgroundBalancing Positive and Negative Selection: In Vivo Evolution of Candida lusitaniae MRR1
Demers, E. G., Stajich, J., Ashare, A., Occhipinti, P., & Hogan, D. A. (2021) · mBio · doi:10.1128/mbio.03328-20 · Cited by 20
“conditions, including exposure to azoles (10, 24), bacterium-produced toxins, including phenazines (10), and host-produced antifungal peptides, including histatin 5 (10, 39).”
BackgroundInfluentialHyperexpression of CDRs and HWP1 genes negatively impacts on Candida albicans virulence
Maras, B., Maggiore, A., Mignogna, G., D’Erme, M., & Angiolella, L. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252555 · Cited by 19
“Expression of this drug efflux pump is under control of the multidrug resistant regulator 1 (MRR1) and its costitutive activity may reside on gainof-function-mutations occurring in clinical isolates from human patients after prolonged fluconazole treatment [27].”
BackgroundGenome-wide functional analysis inCandida albicans
Motaung, T. E., Ells, R., Pohl, C. H., Albertyn, J., & Tsilo, T. J. (2017) · Virulence · doi:10.1080/21505594.2017.1292198 · Cited by 19
Ramírez-Zavala, B., Manz, H., Englert, F., Rogers, P. D., & Morschhäuser, J. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01655-18 · Cited by 20
Self-citationFeng, W., Yang, J., Ji, Y., Xi, Z., Yang, L., Zhu, X., & Ma, Y. (2019) · Letters in Applied Microbiology · doi:10.1111/lam.13248 · Cited by 20
“At present, a lot of studies are focused on zinc cluster transcription factors in C. albicans such as Rep1p, Tac1p, Upc2p, Mrr1p and Cap1p (Coste et al. 2007; Morschhauser et al. 2007; Chen et al. 2009; Lohberger et al. 2014), while the research on Mrr2 remains relatively rare.”
BackgroundBiermann, A. R., Demers, E. G., & Hogan, D. A. (2020) · Molecular Microbiology · doi:10.1111/mmi.14604 · Cited by 18
Wang, X., Liu, J., Chen, J., Zhang, M., Tian, C., Peng, X.-P., Li, G., Chang, W., & Lou, H. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.104771 · Cited by 18
Butts, A., Reitler, P., Nishimoto, A. T., DeJarnette, C. A., Estredge, L. R., Peters, T. L., Veve, M. P., Rogers, P. D., & Palmer, G. E. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00054-19 · Cited by 18
“Total cellular RNA was extracted using the hot phenol method (52). cDNA was synthesized from total RNA using a Verso cDNA synthesis kit (Thermo Scientific), in accordance with the manufacturer’s instructions, and was used as the template for amplification of ACT1, MDR1, CDR1, or CDR2 transcripts using Maxima SYBR gree…”
BackgroundInfluentialSelf-citationExploration of novel mechanisms of azole resistance in Candida auris
Li, J., Brandalise, D., Coste, A. T., Sanglard, D., & Lamoth, F. (2024) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01265-24 · Cited by 19
“These high MDR1 expression levels were conserved in the background strain lacking MRR1 , which is known to regulate MDR1 in Candida spp. (23, 38).”
Overexpression approaches to advance understanding of Candida albicans
Rai, L. S., van Wijlick, L., Chauvel, M., d’Enfert, C., Legrand, M., & Bachellier‐Bassi, S. (2021) · Molecular Microbiology · doi:10.1111/mmi.14818 · Cited by 20
Yin, Y., Zhang, H., Zhang, Y., Hu, C., Sun, X., Liu, W. Y., & Li, S. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01316-20 · Cited by 17
“ADS-1 and its homologs clustered into a distinct clade, which was clearly separated from AtrR, Mrr1p, and Stb5p.”
BackgroundInfluentialHow fungal multidrug transporters mediate hyper resistance through DNA amplification and mutation
Banerjee, A., Rahman, H., Prasad, R., & Golin, J. E. (2022) · Molecular Microbiology · doi:10.1111/mmi.14947 · Cited by 17
Bhattacharya, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819990-9.00070-6 · Cited by 18
Lanna, M., Lovatto, J. E., de Almeida, J. N., Medeiros, E. A., Colombo, A. L., & García‐Effrón, G. (2025) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2025.101546 · Cited by 16
Cph1p negatively regulates MDR1 involved in drug resistance in Candida albicans
Lo, H., Tseng, K., Kao, Y.-Y., Tsao, M.-Y., Lo, H.-L., & Yang, Y.-L. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.01.017 · Cited by 15
d’Enfert, C., & Bougnoux, M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.00139-2 · Cited by 16
Schulz, B., Weber, K., Schmidt, A., Zepelin, M. B., & Ruhnke, M. (2011) · Mycoses · doi:10.1111/j.1439-0507.2010.01970.x · Cited by 18
Luna-Tapia, A., Butts, A., & Palmer, G. E. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01337-18 · Cited by 14
“However, a combination of the aforementioned mechanisms is usually necessary to confer clinically relevant levels of azole resistance (3, 4, 8, 9).”
BackgroundXue, W., Yin, Y., Ismail, F., Hu, C., Zhou, M., Cao, X., Li, S., & Sun, X. (2019) · Current Genetics · doi:10.1007/s00294-018-0924-7 · Cited by 14
Yeasts Acquire Resistance Secondary to Antifungal Drug Treatment by Adaptive Mutagenesis
Quinto‐Alemany, D., Canerina‐Amaro, A., Hernández-Abad, L. G., Machín, F., Romesberg, F. E., & Gil‐Lamaignere, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042279 · Cited by 17
“This clinically important fungus can cause lifethreatening systemic infections, especially in immunocompromised patients [25].”
The function and regulation of heat shock transcription factor in Cryptococcus
Suo, C., Gao, Y., Ding, C., & Sun, T. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1195968 · Cited by 14
Sasse, C., Schillig, R., Reimund, A., Merk, J., & Morschhäuser, J. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00264-12 · Cited by 14
“The MDR1 promoters were induced by growing the cells in the presence of benomyl or H2O2 and GFP expression in the reporter strains was quantified by flow cytometry as described previously (18).”
BackgroundMethodSelf-citationMechanisms of Drug Resistance in Fungi and Their Significance in Biofilms
Prasad, R., Shah, A. H., & Dhamgaye, S. (2014) · Springer series on biofilms · doi:10.1007/978-3-642-53833-9_4 · Cited by 14
Bencova, A., Goffa, E., Morvová, M., Valachovič, M., Griač, P., Hervay, N. T., & Gbelská, Y. (2020) · Mycopathologia · doi:10.1007/s11046-020-00459-4 · Cited by 12
Zhao, Y., Sun, H., Li, J., Ju, C., & Huang, J. (2022) · Biology · doi:10.3390/biology11020326 · Cited by 14
“Another zinc transcription factor, Mrr1, regulates the expression of the MFS transporter Mdr1 [46].”
BackgroundStrain variation in gene expression impact of hyphal cyclin Hgc1 in Candida albicans
Sharma, A., & Mitchell, A. P. (2023) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkad151 · Cited by 12
“The outcomes mirrored previous findings regarding strain variation in the impact of transcription factor gene mutations (Morschhäuser et al. 2007; Huang et al. 2019; Do et al. 2022; Cravener et al. 2023; Mao et al. 2023).”
The TAC1 Gene in Candida albicans : Structure, Function, and Role in Azole Resistance: A Mini-Review
Mahdizade, A. H., Hoseinnejad, A., Ghazanfari, M., Boozhmehrani, M. J., Bahreiny, S. S., Abastabar, M., Galbo, R., Giuffrè, L., Haghani, I., & Romeo, O. (2024) · Microbial Drug Resistance · doi:10.1089/mdr.2023.0334 · Cited by 12
“44,45 Furthermore, analyzing the data from 12 resistant isolates compared with that from 3 isolates with a knocked-out TAC1 gene revealed strong suppression of CDR1 and CDR2 expression in the knocked-out strains, even compared with the sensitive strains.”
Ibe, C., & Pohl, C. H. (2024) · The Lancet Microbe · doi:10.1016/j.lanmic.2024.100996 · Cited by 12
Antifungal Targets, Mechanisms of Action, and Resistance in Candida albicans
Akins, R. A., & Sobel, J. D. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-180-2_29 · Cited by 15
Palmarumycin P3 Reverses Mrr1-Mediated Azole Resistance by Blocking the Efflux Pump Mdr1
Song, M., Zhang, M., Lu, J., Xie, F., Song, J., Luan, X., Hou, X., Lou, H., & Chang, W. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02126-21 · Cited by 12
“albicans, MDR1 overexpression is mainly the result of gain-of-function mutations in the transcription factor Mrr1 (7).”
BackgroundCandida auris ve Antifungal İlaçlara Direnç Mekanizmaları
Alp, Ş., & Arıkan-Akdağlı, S. (2021) · Mikrobiyoloji Bulteni · doi:10.5578/mb.20217 · Cited by 14
What ‘Omics can tell us about antifungal adaptation
Ribeiro, G. F., Denes, E., Heaney, H., & Childers, D. S. (2021) · FEMS Yeast Research · doi:10.1093/femsyr/foab070 · Cited by 11
Morschhäuser, J. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012643 · Cited by 9
“The introduction of these mutations into the fluconazole-susceptible C . albicans reference strain SC5314 caused constitutive MDR1 overexpression and increased drug resistance, with a stronger effect when no wild-type allele was present [70].”
BackgroundInfluentialSelf-citationCandida albicans mutant construction and characterization of selected virulence determinants
Motaung, T. E., Albertyn, J., Pohl, C. H., & Köhler, G. A. (2015) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2015.06.004 · Cited by 9
Hoehamer, C. F., Cummings, E. D., Hilliard, G. M., Morschhäuser, J., & Rogers, P. D. (2009) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200800252 · Cited by 10
“G5 Clinical isolate from patient G, fluconazole-resistant Mrr1p G997V [17] [10] 5833 Clinical isolate, fluconazole-susceptible – – – [20] 6692 Clinical isolate, fluconazole-resistant Mrr1p T360I, K335N [22] [20] Gu2 Clinical isolate, fluconazole-susceptible – – – [11] Gu5 Clinical isolate, fluconazole-resistant Tac1p…”
BackgroundResultSelf-citationMechanisms of Resistance to Antifungal Agents
White, T. C., & Hoot, S. J. (2011) · Wiley eBooks · doi:10.1128/9781555816728.ch127 · Cited by 10
Azole Antifungal Drugs: Mode of Action and Resistance
Garcia‐Rubio, R., Monteiro, M. C., & Mellado, E. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809633-8.20731-0 · Cited by 9
Hiyama, Y., Sato, T., Takahashi, S., Yamamoto, S., Ogasawara, N., Masumori, N., & Yokota, S. (2021) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2021.115556 · Cited by 9
The role of non-standard translation in Candida albicans pathogenesis
Bezerra, A. R., Oliveira, C., Correia, I., Guimarães, A. R., Sousa, G., Carvalho, M. J., Moura, G. R., & Santos, M. A. S. (2021) · FEMS Yeast Research · doi:10.1093/femsyr/foab032 · Cited by 8
Transcriptional Response of Candida auris to the Mrr1 Inducers Methylglyoxal and Benomyl
Biermann, A. R., & Hogan, D. A. (2022) · mSphere · doi:10.1128/msphere.00124-22 · Cited by 9
Intra-platform comparison of 25-mer and 60-mer oligonucleotide Nimblegen DNA microarrays
Fénart, S., Chabi, M., Gallina, S., Huis, R., Neutelings, G., Rivière, N., Thomasset, B., Hawkins, S., & Lucau‐Danila, A. (2013) · BMC Research Notes · doi:10.1186/1756-0500-6-43 · Cited by 11
“Nimblegen 25-mers arrays were successfully used in gene expression analyses in bacteria [11], yeast [12], and human [13].”
MethodCandida albicans: a historical overview of investigations into an important human pathogen
Shrivastava, M., & Whiteway, M. S. (2025) · Canadian Journal of Microbiology · doi:10.1139/cjm-2025-0036 · Cited by 7
Insights into the role of sphingolipids in antifungal drug resistance
Kalra, S., Tanwar, S., & Bari, V. K. (2023) · Fungal Biology Reviews · doi:10.1016/j.fbr.2023.100342 · Cited by 8
Barker, K. S., Zhang, Q., Peters, T. L., Rybak, J. M., Morschhäuser, J., Cuomo, C. A., & Rogers, P. D. (2025) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2025.10.009 · Cited by 7
Self-citationBruzual, I., & Kumamoto, C. A. (2011) · Molecular Genetics and Genomics · doi:10.1007/s00438-011-0650-z · Cited by 8
“Under these conditions, GFP fluorescence in the strains carrying either the A or G allele was high (data not shown), presumably due to the transactivating MRR1 mutation (Morschhauser et al. 2007; Dunkel et al. 2008; Schubert et al. 2008).”
InfluentialMechanisms of Drug Resistance in Candida albicans
Sanglard, D. (2017) · Springer eBooks · doi:10.1007/978-3-319-50409-4_15 · Cited by 11
Azoles Used in Agriculture as Possible Cause of Azole-Resistance in Clinical Candida Isolates
Kaur, H., Yadav, A., Wadhwa, K., Jain, K., & Ghorai, S. M. (2021) · Biosciences Biotechnology Research Asia · doi:10.13005/bbra/2884 · Cited by 7
Meng, Y., Ni, Y., Li, Z., Jiang, T., Sun, T., Li, Y., Gao, X., Li, H., Suo, C., Li, C., et al. (2024) · eLife · doi:10.7554/elife.85728 · Cited by 7
Self-citationStrain variation in Candida albicans glycolytic gene regulation
Kim, M.-J., White, A. M., & Mitchell, A. P. (2024) · mSphere · doi:10.1128/msphere.00579-24 · Cited by 7
“This puzzle was evident in pioneering studies from Morschhauser and Rogers on Mrr1-regulated genes (37), and in our own studies on biofilm/hyphal regulators, and iron regulators (15–17, 19, 35, 36, 38).”
Ibe, C., Otu, A. A., & Pohl, C. H. (2025) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2024.2448844 · Cited by 7
“MDR1 expression is regulated by the transcription factor, MRR1 ( MRR1A in C. auris ), whose GoF mutations lead to overexpression of MDR1 and increase resistance to fluconazole in C. albicans [26,27].”
Rifampicin induced virulence determinants increase Candida albicans biofilm formation
Vogel, M., Köberle, M., Schäffler, H., Treiber, M. K., Autenrieth, I. B., & Schumacher, U. (2013) · F1000Research · doi:10.12688/f1000research.2-106.v1 · Cited by 7
Balzi, E., & Moye-Rowley, S. (2018) · Yeast · doi:10.1002/yea.3354 · Cited by 7
“C. albicans still co‐regulates many of these same targets but does so using transcription factors (Tac1, Mrr1) that are not closely related to either Pdr1 or Pdr3 (Coste, Karababa, Ischer, Bille, & Sanglard, 2004; Morschhauser et al., 2007).”
BackgroundThe emerging pathogen Candida auris: host interactions and disease drivers
Sanya, D. R. A., Arevalo, A. V., Onésime, D., & Nobile, C. J. (2026) · Journal of Biomedical Science · doi:10.1186/s12929-026-01230-5 · Cited by 6
“The transcription factor Mrr1 regulates azole resistance through control of the Mdr1 efflux pump [126–129] and also governs genes involved in methylglyoxal detoxification [130].”
Levi, O., Zuchman, R., Sleman, N., Koren, R. N., Khamaisi, H., & Horwitz, B. A. (2025) · mBio · doi:10.1128/mbio.01909-25 · Cited by 7
“…arises from modifications in the ergosterol pathway, including point mutations in ERG11 and overexpression of target enzymes (12), as well as drug expul sion from the cell through overexpression of multidrug transporters belonging to the ATP-binding cassette (ABC) superfamily (11, 13–16).”
Prusty, J. S., Kumar, A., & Kumar, A. (2024) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2024.2418125 · Cited by 8
“Accordingly, fluconazole resistance in many clinical C. albicans isolates occurs due to the overexpression of multidrug efflux pumps MDR1 and cDR1/cDR2, driven by GOF mutations in transcription factors Mrr1 and tac (Morschhäuser et al. 2007; coste et al. 2009).”
Kumar, A., Francis, A., Hans, S., & Thakur, A. (2024) · Springer eBooks · doi:10.1007/978-981-97-4909-6_8 · Cited by 7
Characterization of the Candida glabrata Transcription Factor CgMar1: Role in Azole Susceptibility
Pais, P., Galocha, M., Califórnia, R., Viana, R., Ola, M., Okamoto, M., Chibana, H., Butler, G., & Teixeira, M. C. (2022) · Journal of Fungi · doi:10.3390/jof8010061 · Cited by 6
“In fact, the MFS transporters CgTPO1_1 and CgTPO4, and the ABC transporter CgYOR1 were found to have increased expression in the ∆cgmar1 mutant.”
BackgroundInfluentialSanglard, D. (2011) · Current Fungal Infection Reports · doi:10.1007/s12281-011-0055-9 · Cited by 7
“Similarly to CDR1/2 upregulation by TAC1, MDR1 overexpression is also caused by GOF mutations in its regulator, Mrr1 [ 80 ].”
BackgroundInfluentialGenome Diversity and Dynamics in Candida albicans
d’Enfert, C., Bougnoux, M., Feri, A., Legrand, M., Loll‐Krippleber, R., Marton, T., Maufrais, C., Ropars, J., Sertour, N., & Sitterlé, E. (2017) · Springer eBooks · doi:10.1007/978-3-319-50409-4_11 · Cited by 6
The Ins and Outs of Azole Antifungal Drug Resistance: Molecular Mechanisms of Transport
Zavřel, M., Esquivel, B. D., & White, T. C. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0667-3_29-1 · Cited by 7
Cuan, R., Liu, S., Zhou, C., Wang, S., Zheng, Y., & Yuan, Y. (2024) · Microorganisms · doi:10.3390/microorganisms12050888 · Cited by 6
Ramírez-Zavala, B., Krüger, I., Schwanfelder, S., Barker, K. S., Rogers, P. D., & Morschhäuser, J. (2024) · mSphere · doi:10.1128/msphere.00270-24 · Cited by 6
“Gain-of-function (GOF) mutations in these transcription factors result in constitutive overexpression of their target genes and are a common cause of acquired fluconazole resistance in clinical C. albicans isolates (4, 6, 8–17).”
BackgroundSelf-citationGunio, D. A., Froehlig, J. R., Pappas, K., Ferguson, U., & Wade, H. (2016) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00704 · Cited by 6
Rodríguez, A. E. R., Pérez, J. E., Hernandez, J., & Zapata, Y. (2020) · Biomédica · doi:10.7705/biomedica.4723 · Cited by 8
“Los hallazgos del presente estudio sustentan la necesidad de secuenciar los genes MDR1 y CDR1 para determinar las implicaciones de las mutaciones en ausencia o en presencia de resistencia en las cepas encontradas en los hospitales locales, mutaciones que se han descrito en diversos estudios (42,43).”
BackgroundStructure–Function Analyses of Multidrug Transporters
Lamping, E., Madani, G., Lee, H. J., Niimi, M., & Cannon, R. D. (2017) · Springer eBooks · doi:10.1007/978-3-319-50409-4_18 · Cited by 5
The small GTPase Rhb1 is involved in the cell response to fluconazole inCandida albicans
Chen, Y., Yeh, Y.-C., Chen, H.-F., Chen, R.-C., Lin, G.-Y., Chen, Y.-T., & Lan, C. (2019) · FEMS Yeast Research · doi:10.1093/femsyr/foz005 · Cited by 5
Bois, A. C. D., Xue, A., Pham, C., Revie, N. M., Meyer, K. J., Yashiroda, Y., Boone, C. M., Nodwell, J. R., Stogios, P. J., Savchenko, A. V., et al. (2022) · mSphere · doi:10.1128/msphere.00075-22 · Cited by 7
“F5 and G5 represent clinical isolates that overexpress the major facilitator transporter Mdr1 due to substitutions in the transcriptional activator Mrr1 (8, 9).”
BackgroundAntifungal Resistance: Cellular and Molecular Mechanisms
Araújo, R., & Espinel‐Ingroff, A. (2010) · Springer eBooks · doi:10.1007/978-3-642-12173-9_7 · Cited by 6
Manoharlal, R., Sharma, M., & Prasad, R. (2010) · Bioscience Reports · doi:10.1042/bsr20100015 · Cited by 5
Molecular Detection of Antifungal Resistance
Edlind, T. D. (2011) · Wiley eBooks · doi:10.1128/9781555816834.ch44 · Cited by 5
Day, A. W., & Kumamoto, C. A. (2024) · PLoS ONE · doi:10.1371/journal.pone.0298724 · Cited by 4
“Perhaps C6_04190C plays a role in zinc uptake or zinc sequestration, which could affect zinc-binding transcriptional regulators that are involved with fluconazole resistance such as Mrr1, Mrr2, Tac1, and Upc2 [86–88].”
BackgroundRamírez-Zavala, B., Hoffmann, A., Krüger, I., Schwanfelder, S., Barker, K. S., Rogers, P. D., & Morschhäuser, J. (2024) · mSphere · doi:10.1128/msphere.00388-24 · Cited by 4
Self-citationRajesh-Khanna, D.-S., Páez, C. G. P., He, S., Dolan, E. G., Mirpuri, K. S., Stajich, J., & Hogan, D. A. (2025) · mBio · doi:10.1128/mbio.01323-25 · Cited by 4
“Beyond drug efflux, the C. lusitaniae Mrr1 regulon (Table S1A) included genes involved in other transporter activities like oligopeptide transport ( OPT1 ), and chemical and stress response, which is consistent with published Mrr1 regulons of C. albicans (23) and C. parapsilosis (28, 35).”
InfluentialThe S862C amino acid change in CpMrr1 confers fluconazole resistance in Candida parapsilosis
Franconi, I., Poma, N. V., Rizzato, C., Maltinti, L., Falcone, M., Tavanti, A., & Lupetti, A. (2025) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlaf051 · Cited by 4
Shi, H., Chang, W., Zhang, M., & Lou, H. (2019) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(19)30023-8 · Cited by 7
Yang, H. Y., Huang, W., Fan, S., Xue, W., Liu, Y., He, Q., Song, M., Wu, W., Wang, L. F., & Lin, C. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.138463 · Cited by 3
Sousa, G., Correia, I., & Bezerra, A. R. (2026) · Microorganisms · doi:10.3390/microorganisms14020273 · Cited by 3
“These increased levels are driven by the overexpression of MRR1 , a putative Zn(II) 2 Cys 6 transcription factor that regulates MDR1 transcription [72].”
Using Yeast to Discover Inhibitors of Multidrug Efflux in Candida albicans
Monk, B. C., & Keniya, M. V. (2017) · Springer eBooks · doi:10.1007/978-3-319-50409-4_23 · Cited by 5
Antifungal Resistance in Candida albicans
Seyedjavadi, S. S., Hatami, F., & Jahanshiri, Z. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1004578 · Cited by 3
Wu, Z., Zhang, J., Zhang, B., Yu, C., Wang, Z., Hao, Z., Hao, J. J., Liu, P., & Liu, X. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.143520 · Cited by 3
Resistance to Antifungal Drugs
Sanglard, D. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6640-7_9 · Cited by 4
Huang, M., Yang, L., Zhou, L., Sun, C., Zhao, W., Peng, J., Jiao, Z., Tian, C., & Guo, G. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.990318 · Cited by 3
Soontorngun, N., Somboon, P., & Watchaputi, K. (2019) · Springer eBooks · doi:10.1007/978-3-030-21110-3_13 · Cited by 3
Transcriptome in Human Mycoses
Peres, N. T. A., Persinoti, G. F., Lang, E. A. S., Rossi, A., & Martinez-Rossi, N. M. (2014) · Springer eBooks · doi:10.1007/978-3-319-11985-4_13 · Cited by 4
Qin, Y., Lv, Q., Xu, H., Cao, Y., & Han, B. (2025) · Mycology: An International Journal on Fungal Biology · doi:10.1080/21501203.2024.2432424 · Cited by 2
“In addition, the expression of MRR1 was upregulated in the parental SN250 strain but not in the hap2Δ/Δ mutant in the RNA-seq, which indicated that the downregulation of MDR1 may related to MRR1 (Morschhäuser et al. 2007).”
The molecular basis of intrinsic resistance to azoles in Rhizopus arrhizus
Lackner, M., Toepfer, S., Keniya, M. V., Lax, C., Nicolás, F. E., Garre, V., Müller, C., Rosam, K., Zenz, L.-M., Cesarini, L., et al. (2025) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01337-25 · Cited by 2
“This lack of effect is most likely due to the presence of efflux pumps, for which fluconazole is a preferred substrate (44, 45).”
AutoactivatedKlPDR1gene in the control of multidrug resistance inKluyveromyces lactis
Hervay, N. T., Hodurova, Z., Balazfyova, Z., & Gbelská, Y. (2011) · Canadian Journal of Microbiology · doi:10.1139/w11-071 · Cited by 2
“…CaMrr1p in Candida albicans and CgPdr1p, CgMrr1p in Candida glabrata respectively, also induce their own expression, which may allow a stronger response to inducing conditions (Vermitsky and Edlind 2004; Tsai et al. 2006; Vermitsky et al. 2006; Morschhäuser et al. 2007; Znaidi et al. 2007).”
BackgroundEmergence of Multidrug Resistance Microbes: Bacteria, Fungi, and Viruses
Malhotra, N., Kumar, P., Ramakrishnan, S., & Rohaun, S. K. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815080056123020005 · Cited by 2
Wang, Y., Guo, X., Zhang, X., Chen, P., Wang, W., Hu, S., Ma, T., Zhou, X., Li, D., & Yang, Y. (2023) · Journal of Fungi · doi:10.3390/jof9080815 · Cited by 1
Jonani, B. (2025) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2025.108201 · Cited by 2
Unnikrishnan, V. K., Sundaramoorthy, N. S., Manivannan, R., Shanthi, M., Gnanadhas, D. P., Alexandar, S. P., Ulaganathan, V., Ramesh, S., & Nagarajan, S. (2025) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2025.130529 · Cited by 1
Zhang, W., Chen, J., Fang, M., Song, M., Gao, Z., Hao, J., Xu, Z., Li, X., Zheng, S., Chang, W., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c03455 · Cited by 1
Exporter Mdr1 as an importer is an achilles’ heel for combating drug-resistant Candida
Chen, J., Zhang, M., Wang, Y., Xie, Z., Yang, F., Yu, H., Zhang, D., Fang, M., Luan, X., Jin, X., et al. (2026) · Cell chemical biology · doi:10.1016/j.chembiol.2026.01.009 · Cited by 1
Bunz, O., Gerke, J., Bader, O., Bastakis, E., Aden, M., Heimel, K., Bürgers, R., Braus, G. H., & Sasse, C. (2026) · Scientific Reports · doi:10.1038/s41598-026-47215-0 · Cited by 1
“In contrast to the ten categories of the up-regulated genes, only two significantly enriched categories (transport mechanism and virulence) for the down-regulated genes were identified (Fig.”
Wongsuwanlert, M., Sangthawan, P., Ruangsri, P., Teanpaisan, R., Teerakanok, S., & Pahumunto, N. (2026) · BMC Oral Health · doi:10.1186/s12903-026-08906-2 · Cited by 1
Choi, Y., Heitman, J., & Won, E. J. (2026) · PLoS Pathogens · doi:10.1371/journal.ppat.1014356 · Cited by 1
In vitro synergistic activity of betulinic acid combined with azoles against pathogenic fungi
Zhang, H., Ge, L., Peng, M., Tang, M., Zeng, Y., Sun, C., & Sun, Y. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1835794 · Cited by 1
Indrajith, M. D. A., & Brandão, J. C. (2026) · Water Research · doi:10.1016/j.watres.2026.126668 · Cited by 1
Fine-Scale Chromosomal Changes in Fungal Fitness
Fischer, D., Hube, B., & Brunke, S. (2014) · Current Fungal Infection Reports · doi:10.1007/s12281-014-0179-9 · Cited by 1
Metadata
- Authors
- Morschhäuser, J., Barker, K. S., Liu, T. T., Blaß-Warmuth, J., Homayouni, R., & Rogers, P. D.
- Affiliations
- University of Würzburg (DE)
- University of Tennessee Health Science Center (US)
- University of Memphis (US)
- Corresponding author
- Morschhäuser, Joachim
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2007-11-02
- Volume
- 3
- Issue
- 11
- Pages
- e164
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC2048531
- OpenAlex
- W2008837893
- Cited by
- 355
- References
- 51
- Citations by year
- 2026: 16 · 2025: 22 · 2024: 17 · 2023: 22 · 2022: 18 · 2021: 18 · 2020: 23 · 2019: 32 · 2018: 14 · 2017: 25 · 2016: 14 · 2015: 13 · 2014: 22 · 2013: 15 · 2012: 16
- FWCI
- 10.35
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Deutsche Forschungsgemeinschaft (SFB 630, MO 846/3)
- National Institutes of Health (AI058145)
- National Institute of Allergy and Infectious Diseases (R01AI058145, AI058145, R21AI058145)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- MRR1, MDR1, multidrug resistance, Candida albicans, fluconazole resistance, transcription factors, efflux pumps, zinc cluster transcription factors, oxidative enzymes, drug resistance mutations, gene expression regulation, antifungal resistance
- MeSH terms
- Antifungal Agents, Base Sequence, Candida albicans, Flow Cytometry, Humans, Molecular Sequence Data, Mutation, Transcription Factors, Blotting, Southern, Fluconazole, Gene Expression, Gene Expression Regulation, Fungal, In Situ Hybridization, Genes, MDR, Reverse Transcriptase Polymerase Chain Reaction, ATP Binding Cassette Transporter, Subfamily B, Member 1, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Drug Resistance, Multiple, Fungal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.